International Vaccine Access Center
Featured
Now Available: 2024 PDPR
The 2024 edition of IVAC’s Pneumonia and Diarrhea Progress Reports provides an analysis of 10 key indicators in the 15 countries with the greatest burden of under-five pneumonia and diarrhea deaths in young children.
Celebrating the Public Health Career of Lois Privor-Dumm
Lois Privor-Dumm reflects on her career at IVAC.
Case Study: Accelerating Vaccine Access in a Post COVID-19 Environment
The case study provides insight on overcoming challenges and optimizing vaccine rollouts.
Accelerating global access to life-saving vaccines.
We apply rigorous science to build knowledge and support for the value of vaccines.
IVAC's Work
The International Vaccine Access Center accelerates equitable and sustainable access to vaccines in low- and middle-income countries by generating, synthesizing, and using evidence to inform decision making and action.
Where We Work
IVAC works with governments and major research institutions in 38 countries. Learn more about us.
What We Do: Project Highlights
Vaccine Information and Epidemiology Window (VIEW-HUB)
VIEW-hub is IVAC’s publicly accessible interactive platform to visualize real-time information on vaccine use, product type, coverage levels, impact assessments, and disease burden estimates. It can be utilized to track progress and strategize ways to accelerate and optimize vaccine implementation.
READ MORE>
Vaccine Economics Research for Sustainability & Equity (VERSE)
VERSE will compute the economic benefits and return-on-investment of vaccines, create a standardized model for assessing, tracking, and targeting vaccine coverage inequity at the country level and for monetizing the economic losses due to inequity, and more.
READ MORE >
Stay Connected
Sign up for our monthly newsletter to receive the latest updates on immunization-related science, policy, and access from the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health.